- Blackstone Life Sciences and Boston Scientific are collaborating on the Vitalyst heart pump.
Blackstone Life Sciences agreed a $455 million collaboration to co-fund development of Boston Scientific's Vitalyst heart pump, a device intended for patients with cardiogenic shock.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.